Alpha Teknova, Inc. (TKNO): Shareholders' Equity
$68.78M
As of 2025-12-31
$62.60M
As of 2026-06-30
-11.7%
3-year compound annual growth
+32.6%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $68.78M | -16.5% | 2026-03-02, Balance as of period end |
| 2024-12-31 | $82.39M | -8.5% | 2026-03-02, Balance as of period end |
| 2023-12-31 | $90.04M | -9.9% | 2025-03-07, Balance as of period end |
| 2022-12-31 | $99.89M | -30.2% | 2024-03-27, Balance as of period end |
| 2021-12-31 | $143.20M | +754.1% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $16.77M | n/a | 2022-03-18, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $68.78M | -16.5% |
| Immucell Corp (ICCC) | 2025-12-31 | $27.06M | -1.7% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $671.39M | -23.0% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | -$6.93M | n/m |
| Anbio Biotechnology (NNNN) | 2025-12-31 | $30.16M | +75.4% |
| Biomerica Inc (BMRA) | 2026-05-31 | $2.63M | -35.9% |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | -$31.46M | n/m |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $368.00M | -47.5% |
| Neogen Corp (NEOG) | 2026-05-31 | $2.09B | +1.0% |
Compare TKNO, ICCC, NTLA, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗